San Francisco Business Times -- Codexis Inc. signed a new agreement to expand its work with generic drug maker Teva Pharmaceutical Industries Ltd. The two companies signed an earlier deal in January. Redwood City’s Codexis will sell its technology to Teva for use in making three drugs that weren’t identified. Codexis makes biocatalysts that speed up drug making.
